Doak Peter Doolittle, MD | |
807 N Ash St, Gordon, NE 69343-1132 | |
(308) 282-1442 | |
(308) 282-1428 |
Full Name | Doak Peter Doolittle |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 807 N Ash St, Gordon, Nebraska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013987064 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 16268 (Nebraska) | Secondary |
208D00000X | General Practice | 04-19991 (Kansas) | Secondary |
208600000X | Surgery | R8D67 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Doak Peter Doolittle, MD 807 N Ash St, Gordon, NE 69343-1132 Ph: (308) 282-1442 | Doak Peter Doolittle, MD 807 N Ash St, Gordon, NE 69343-1132 Ph: (308) 282-1442 |
News Archive
Ahead of Mother's Day on May 13, UNAIDS Executive Director Michel Sidibe writes in this post in the Huffington Post's "Global Motherhood" blog, "Together we can go from 390,000 children becoming infected with HIV each year to zero," and he highlights "three simple things we can all do to ensure babies everywhere can be born free from HIV."
A.D.A.M., Inc., a leading provider of consumer health information, benefits technology solutions and online education resources, today announced the availability of Anatomy Practice online—the newest in its line of web based educational resources for college level courses. This most recent addition to the A.D.A.M. Education suite of online resources and curriculum development products is designed to assist both students and school instructors.
Neurologix has announced positive interim results of its landmark gene therapy clinical trial for patients with Parkinson's disease. Neurologix's 12-patient, dose-escalating Phase I trial is the world's first study to use a viral vector (the non-pathogenic adeno-associated virus, or AAV) for the treatment of an adult neurological disease.
Skin diseases affect half of the world's population, but many treatments are not effective, require frequent injections, or cause significant side effects.
› Verified 8 days ago